Home The Word Brain My Amedeo FAQ Privacy About   

As of October 2023, Amedeo had
12,263 active subscribers


  Free Subscription


1 Am J Cardiol
1 Am J Epidemiol
4 Am J Hypertens
2 Clin Cardiol
2 Hypertension
2 J Cardiovasc Pharmacol
2 J Hum Hypertens
21 J Hypertens
1 Kidney Int
1 Neurology
2 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Cardiol

  1. KRISHTOPAYTIS E, Ampnti SA, Obeidat M, Ramahi N, et al
    Can Inhaled Nitric Oxide Response Predict Tolerance to Therapies and Survival in Patients With Combined Precapillary and Postcapillary Pulmonary Hypertension?
    Am J Cardiol. 2023;207:363-369.
    PubMed         Abstract available

    Am J Epidemiol

  2. FRANCIS B, Pearl M, Colen C, Shoben A, et al
    Racial and Economic Segregation Over the Lifecourse and Incident Hypertensive Disorders of Pregnancy among Black Women in California.
    Am J Epidemiol. 2023 Sep 28:kwad192. doi: 10.1093.
    PubMed         Abstract available

    Am J Hypertens

  3. SARNHOLM J, Kronish IM
    Psychological distress and hypertension diagnostic testing: Is there anything to worry about?
    Am J Hypertens. 2023 Oct 5:hpad096. doi: 10.1093.

  4. ZANUZZI MG, Lopez SM, Cattaneo MJ, Perez-Maure MA, et al
    Isolated Nocturnal Hypertension in People Living with Human Immunodeficiency Virus (PWH): A Cross-Sectional Study.
    Am J Hypertens. 2023 Sep 30:hpad087. doi: 10.1093.
    PubMed         Abstract available

  5. SRIPERUMBUDURI S, Welling P, Ruzicka M, Hundemer GL, et al
    Potassium and Hypertension: A State-of-the-Art Review.
    Am J Hypertens. 2023 Sep 29:hpad094. doi: 10.1093.
    PubMed         Abstract available

  6. LEE JS, Bhatt A, Jackson SL, Pollack LM, et al
    Rural and Urban Differences in Hypertension Management Through Telehealth Before and During the COVID-19 Pandemic Among Commercially Insured Patients.
    Am J Hypertens. 2023 Sep 29:hpad093. doi: 10.1093.
    PubMed         Abstract available

    Clin Cardiol

  7. NIU J, Xu D, Huang Y, You J, et al
    Sex-related association of modifiable risk factors with hypertension: A national cross-sectional study of NHANES 2007-2018.
    Clin Cardiol. 2023 Oct 5. doi: 10.1002/clc.24165.
    PubMed         Abstract available

  8. DI GIACOMO D, Ranieri J, Guerra F, Cilli E, et al
    Cardiovascular risk and biopsychosocial interplay: Association among hypertension, anxiety, and emotional dysregulation-observational study in primary care setting for efficient self-care.
    Clin Cardiol. 2023 Sep 28. doi: 10.1002/clc.24152.
    PubMed         Abstract available


  9. ZHANG J, Yin Z, Xu Y, Wei C, et al
    Resolvin E1/ChemR23 Protects Against Hypertension and Vascular Remodeling in Angiotensin II-Induced Hypertensive Mice.
    Hypertension. 2023 Oct 6. doi: 10.1161/HYPERTENSIONAHA.123.21348.
    PubMed         Abstract available

  10. MANCIA G, Kjeldsen SE
    Randomized Clinical Outcome Trials in Hypertension.
    Hypertension. 2023 Oct 5. doi: 10.1161/HYPERTENSIONAHA.123.21725.

    J Cardiovasc Pharmacol

  11. LIU R, Staruschenko A
    Matrix Metalloproteinase 2 is crucial for hypertension- and hyperglycemia-induced kidney injury independent of blood pressure.
    J Cardiovasc Pharmacol. 2023 Sep 28. doi: 10.1097/FJC.0000000000001488.

  12. KAPLAN A, Lakkis B, El-Samadi L, Karaayvaz EB, et al
    Cooling Down Inflammation in the Cardiovascular System via the Nicotinic Acetylcholine Receptor.
    J Cardiovasc Pharmacol. 2023 Aug 4. doi: 10.1097/FJC.0000000000001455.
    PubMed         Abstract available

    J Hum Hypertens

  13. GOSSE P, Boulestreau R, Doublet J, Gaudissard J, et al
    Arterial stiffness (from monitoring of Qkd interval) predict the occurrence of cardiovascular events and total mortality.
    J Hum Hypertens. 2023;37:907-912.
    PubMed         Abstract available

  14. KOURTIDOU C, Georgianos PI, Vaios V, Liakopoulos V, et al
    Prescribing the optimal dialysate sodium concentration for managing hypertension and volume overload in hemodialysis: one size does not fit to all patients.
    J Hum Hypertens. 2023 Oct 4. doi: 10.1038/s41371-023-00870.

    J Hypertens

  15. WIERSINGA JHI, Rhodius-Meester HFM, Wolters FJ, Trappenburg MC, et al
    Orthostatic hypotension and its association with cerebral small vessel disease in a memory clinic population.
    J Hypertens. 2023;41:1738-1744.
    PubMed         Abstract available

  16. LEE SH, Lee CJ, Kang Y, Park JM, et al
    A randomized trial of genotype-guided perindopril use.
    J Hypertens. 2023;41:1768-1774.
    PubMed         Abstract available

  17. SCHMIDT-LAUBER C, Alba Schmidt E, Hanzelmann S, Petersen EL, et al
    Increased blood pressure after nonsevere COVID-19.
    J Hypertens. 2023;41:1721-1729.
    PubMed         Abstract available

  18. SONG J, Tan M, Wang C, Brown MK, et al
    Salt intake, blood pressure and cardiovascular disease mortality in England, 2003-2018.
    J Hypertens. 2023;41:1713-1720.
    PubMed         Abstract available

  19. BROSOLO G, Da Porto A, Bulfone L, Vacca A, et al
    Cortisol secretion and abnormalities of glucose metabolism in nondiabetic patients with hypertension.
    J Hypertens. 2023 Oct 6. doi: 10.1097/HJH.0000000000003590.
    PubMed         Abstract available

    The ATP connection: a new therapeutic promise of P2X7 targeting in hypertension and vascular injury.
    J Hypertens. 2023;41:1696-1698.

  21. SHOKOPLES BG, Berillo O, Comeau K, Chen HY, et al
    P2RX7 gene knockout or antagonism reduces angiotensin II-induced hypertension, vascular injury and immune cell activation.
    J Hypertens. 2023;41:1701-1712.
    PubMed         Abstract available

  22. SHI M, Liu Y, Wang S, Wang R, et al
    Blood pressure control and antihypertensive medication use after discharge and prognosis of ischemic stroke.
    J Hypertens. 2023;41:1730-1737.
    PubMed         Abstract available

  23. CARDOSO AM, Aneli NM, Lammers M, Manica A, et al
    Resistance training reduces platelet activation in hypertensive women: the role of purinergic signaling.
    J Hypertens. 2023;41:1745-1752.
    PubMed         Abstract available

  24. FATIMA HE, Lo DF
    Examining the impact of E-health management on hypertension.
    J Hypertens. 2023;41:1863.

  25. ANDERSSON U, Nilsson PM, Kjellgren K, Hoffmann M, et al
    Reply to 'Examining the impact of E-health management on hypertension'.
    J Hypertens. 2023;41:1864.

    Carvedilol in patients with cirrhosis and arterial hypertension: two birds with one stone.
    J Hypertens. 2023;41:1864-1865.

  27. CUSPIDI C, Gherbesi E, Tadic M
    Phenotyping masked hypertension: do not forget the night.
    J Hypertens. 2023;41:1865-1866.

  28. TABARA Y
    Reply to 'Phenotyping sleep hypertension; never forgetting the night'.
    J Hypertens. 2023;41:1867.

  29. PS-P12-8: The prevalence of hypertension in factory employees, detected during the periodic examination at the factory: Erratum.
    J Hypertens. 2023;41:1868.

  30. Prevalence of non-steroidal anti-inflammatory drugs (NSAIDS) use in patients with hypertensive crisis: Erratum.
    J Hypertens. 2023;41:1871.

  31. Interferon regulatory factor 4 deletion protects against kidney inflammation and fibrosis in deoxycorticosterone acetate/salt hypertension: Erratum.
    J Hypertens. 2023;41:1872.

  32. RIJAL A, Adhikari TB, Dhakal S, Maagaard M, et al
    Effects of adding exercise to usual care on blood pressure in patients with hypertension, type 2 diabetes, or cardiovascular disease: a systematic review with meta-analysis and trial sequential analysis.
    J Hypertens. 2023 Oct 6. doi: 10.1097/HJH.0000000000003589.
    PubMed         Abstract available

  33. BASTA K, Ledwaba-Chapman L, Dodhia H, Ashworth M, et al
    Hypertension prevalence, coding and control in an urban primary care setting in the UK between 2014 and 2021.
    J Hypertens. 2023 Oct 2. doi: 10.1097/HJH.0000000000003584.
    PubMed         Abstract available

  34. PEETERS LEJ, Kappers MHW, Hesselink DA, van der Net JB, et al
    Antihypertensive drug concentration measurement combined with personalized feedback in resistant hypertension: a randomized controlled trial.
    J Hypertens. 2023 Oct 6. doi: 10.1097/HJH.0000000000003585.
    PubMed         Abstract available

  35. DE LA SIERRA A, Ruilope LM, Martinez-Camblor P, Vinyoles E, et al
    Impact of timing of antihypertensive treatment on mortality: an observational study from the Spanish Ambulatory Blood Pressure Monitoring Registry.
    J Hypertens. 2023 Sep 27. doi: 10.1097/HJH.0000000000003581.
    PubMed         Abstract available


  36. HARRIS E
    Majority of People Live With Uncontrolled Hypertension Worldwide.
    JAMA. 2023 Oct 4. doi: 10.1001/jama.2023.19204.

    Kidney Int

  37. EMMONS BR, Batal I, Radhakrishnan J, Husain SA, et al
    Age-related changes in nephrosclerosis in a multiethnic living kidney donor cohort.
    Kidney Int. 2023;104:394-397.


  38. KELLY DM, Georgakis MK, Franceschini N, Blacker D, et al
    Interplay Between Chronic Kidney Disease, Hypertension, and Stroke: Insights From a Multivariable Mendelian Randomization Analysis.
    Neurology. 2023 Sep 29:10.1212/WNL.0000000000207852.
    PubMed         Abstract available

    PLoS One

  39. COSTA S, Guerreiro J, Teixeira I, Helling DK, et al
    Patient preferences and cost-benefit of hypertension and hyperlipidemia collaborative management model between pharmacies and primary care in Portugal: A discrete choice experiment alongside a trial (USFarmacia(R)).
    PLoS One. 2023;18:e0292308.
    PubMed         Abstract available

  40. LEE H, Kim H, Oh S, Park JK, et al
    Delayed blood pressure recovery after exercise stress test is associated with autonomic dysfunction and pulse pressure in a middle-aged healthy group.
    PLoS One. 2023;18:e0285961.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hypertension is free of charge.